ZEUS System vs Cardiomo

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Cardiomo, Inc.

AI Verdict

Both ZEUS System and Cardiomo offer AI-powered, HIPAA-compliant, cloud-based solutions for continuous cardiac monitoring using wearable devices, making them direct competitors. ZEUS focuses on detailed ECG analysis for arrhythmia detection and characterization with physician-centric reporting, while Cardiomo provides broader vital sign monitoring, real-time alerts for users and caregivers, and includes features like fall detection.

Choose ZEUS System if…

Choose the ZEUS System if you are a clinician seeking a comprehensive, FDA-cleared, AI-powered solution for long-term continuous cardiac monitoring, specifically for detecting and characterizing arrhythmias like Atrial Fibrillation. This system is ideal for generating preliminary reports to aid in diagnosis and management, integrating with existing EHR systems, and utilizing a service that includes review by certified cardiographic technicians.

View ZEUS System →

Choose Cardiomo if…

Choose Cardiomo if you require a medical-grade wearable device for continuous, real-time remote heart health monitoring with immediate alerts for users, caregivers, and healthcare providers. This tool is particularly well-suited for monitoring vital signs beyond just ECG, such as respiration and skin temperature, and for use cases where fall detection and timely notifications to a support network are critical, especially for older individuals or those with known cardiovascular risks.

View Cardiomo →

When choosing between the ZEUS System by iRhythm Technologies and Cardiomo, physicians should consider their primary focus for cardiac monitoring. The ZEUS System excels in long-term continuous ECG monitoring, specifically designed for the detection and characterization of arrhythmias like Atrial Fibrillation. Its integration with Zio monitors and cloud-based analytics, including preliminary report generation, makes it suitable for practices requiring detailed, extended ECG analysis for diagnostic purposes.

In contrast, Cardiomo offers a broader approach to remote heart health monitoring with its medical-grade wearable device. Beyond ECG, it continuously monitors vital signs such as heart rate, respiration, and skin temperature, and includes features like fall detection and real-time alerts. The key practical difference lies in ZEUS’s specialized focus on arrhythmia detection via extended ECG, versus Cardiomo’s more comprehensive vital sign monitoring and immediate alert system. Physicians primarily focused on in-depth arrhythmia diagnosis and characterization over an extended period may find the ZEUS System more aligned with their needs. Conversely, those seeking a more holistic, real-time remote monitoring solution with broader vital sign tracking and immediate alerts for a wider range of cardiovascular events, particularly for at-risk populations, might prefer Cardiomo.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ZEUS System Cardiomo
Pricing Not disclosed Contact for pricing
Deployment Cloud-based (AWS EC2 platform), no on-premise hardware. Cloud-based with wearable device and mobile app
FDA Status 1 AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System

The ZEUS System, integrated with Zio monitors, emphasizes ease of use with a single-use patch worn for up to 14 days and a streamlined process for data return and report generation. Cardiomo also highlights ease of use and a long battery life, but the ZEUS System's established integration with Zio monitors and physician workflow suggests a more refined user experience for both patients and clinicians.

Clinical Value

ZEUS System

The ZEUS System has FDA 510(k) clearance and CE Mark certification, with documented clinical validation studies showing high sensitivity and specificity for AFib detection. It also provides a comprehensive end-of-wear report reviewed by certified cardiographic technicians. While Cardiomo states it is medical-grade and has undergone pilot projects and ISO 13485 certification, its FDA approval status is still an application, and specific clinical validation metrics are not as readily available.

Pricing & Value

Tie

Neither company publicly discloses current pricing, making a direct comparison difficult. Cardiomo previously offered a device for $200 with a $10 monthly subscription, but this is not current pricing. Without transparent pricing, it's impossible to determine which offers better value.

Enterprise Readiness

ZEUS System

The ZEUS System is part of iRhythm's broader Zio service, which includes EHR integration and a web portal (ZioSuite) for healthcare professionals to manage clinical workflows. This indicates a more robust infrastructure for enterprise adoption. Cardiomo focuses on real-time alerts to users and caregivers, and while it mentions B2B and B2B2C market approaches, the explicit enterprise features like EHR integration are more prominent for ZEUS.

Innovation

Tie

Both tools leverage AI and wearable technology for continuous cardiac monitoring, demonstrating innovation in remote patient monitoring. ZEUS utilizes deep-learned algorithms and PPG technology for AFib detection, while Cardiomo offers a medical-grade wearable patch monitoring multiple vital signs with real-time alerts and fall detection. Both are pushing the boundaries of what's possible in cardiac health.

Support & Docs

ZEUS System

iRhythm provides extensive documentation for the ZEUS System, including Instructions for Use and Clinical Reference Manuals, which are publicly accessible. This suggests a comprehensive support structure for healthcare professionals. While Cardiomo likely offers support, the level of publicly available documentation is not as extensive as that for the ZEUS System.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ZEUS System Cardiomo
Tool Name ZEUS System Cardiomo
Company iRhythm Technologies Cardiomo, Inc.
Description AI-powered software that analyzes ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. A medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers.
Key Features AI-powered arrhythmia detection, Continuous ECG monitoring (up to 14 days), Cloud-based data analytics, Detection and characterization of Atrial Fibrillation (AFib), Preliminary report generation for physicians, Integration with Zio Watch and Zio monitors, Support for symptomatic and asymptomatic cardiac events, HL7-based EHR integration Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days)
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Geriatrics, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring ZEUS System and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.